Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer

NCT03829722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Squamous Cell Carcinoma

Interventions

DRUG: Nivolumab
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Radiation Therapy

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]